Antiviral Activity of Polyphenols: Latest Developments
Prof. Sascha Venturelli, from the University of Hohenheim, Germany, will be joining the 17th World Congress on Polyphenols Applications 2024 this September in Milan.
He will present the latest developments in the antiviral activity of polyphenols.
Presentation Summary
- The heterogenous class of polyphenols exhibit surprising and interesting antiviral effects.
- The COVID-19 pandemic has also inspired research on polyphenols and their health promoting properties.
- Current research including our own findings show that prenylated flavonoids (e.g. 6-prenylnaringenin) inhibit important viral enzymes of SARS-CoV-2.
- Also other polyphenols (like quercetin and curcumin) exert antiviral effects on SARS-CoV-2.
- Polyphenols seem to be promising natural drug candidates for other human viral diseases (e.g. hepatitis, influenca).
About Sascha Venturelli
Prof. Dr. Dr. Venturelli completed his biology studies at the Albert-Ludwigs-University of Freiburg and received his diploma with distinction in 2002. He successfully completed his medical studies with study visits at University College London Hospitals (Great Britain), Porter Memorial Hospital (USA) and University Hospital Zurich (Switzerland) at the Eberhard Karls University Tübingen in 2008. Both his scientific doctorate at the University of Hohenheim and his medical dissertation at the University Hospital of Tübingen were awarded "summa cum laude".
Initially, Prof. Dr. Dr. Venturelli worked as head of laboratory at the Department of Internal Medicine I at the University Hospital in Tübingen. During this time, he spent a research stay at the Peter MacCallum Cancer Centre in Melbourne (Australia) in the renowned research group of Prof. Ricky Johnstone from 2011 to 2012, funded by the DFG. Upon his return to the University Hospital in Tübingen, he established his own research group focusing on epigenetics and nutrition in the context of oncology as part of the Excellence Initiative of the Eberhard Karls University of Tübingen. In addition to his function as a study physician, during this time new active substances for cancer therapy were identified, characterised and successfully patented by the University Hospital of Tübingen. Prof. Dr. Dr. Venturelli was appointed deputy director of the Department of Vegetative and Clinical Physiology, Eberhard Karls University of Tübingen in 2016 and academic director in 2017.
In addition to various activities in the context of university self-administration such as study and examination commissioner, he was appointed to various national and international committees. In 2019 Prof. Dr. Dr. Venturelli accepted the call for the W3-Professorship at the University of Hohenheim and has since then been head of the Department of Biochemistry of Nutrition at the Institute of Nutritional Sciences.
Polyphenols Applications 2024 Congress
September 19-20, 2024 - Milan
Press Releases | Newsletter Archives
LinkedIn | Facebook
